• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射频消融后复发性肝细胞癌行挽救性肝切除术中开腹与腹腔镜手术的比较。

Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation.

机构信息

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

出版信息

Medicina (Kaunas). 2023 Jul 4;59(7):1243. doi: 10.3390/medicina59071243.

DOI:10.3390/medicina59071243
PMID:37512055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10384708/
Abstract

: Although radiofrequency ablation (RFA) is widely used as an effective local treatment for hepatocellular carcinoma (HCC), evidence on salvage hepatectomy for local recurrence after RFA is limited. This study aims to compare open and laparoscopic approaches in salvage hepatectomy for recurrent HCC after RFA. : Among patients who underwent hepatectomy between January 2004 and August 2022 at a single tertiary referral center, 55 patients who underwent salvage hepatectomy for marginal recurrence after RFA were selected. An open approach was used in 23 (41.8%) patients, while 32 (58.2%) patients underwent laparoscopic surgery. Short-term and long-term outcomes were compared between the two groups. : Major hepatectomy was more often performed in the open group (9 [39.1%] vs. 4 [12.5%], = 0.022). Intraoperative blood loss was also greater in the open group (450 (325-750) vs. 300 (200-600), = 0.034). Operation time ( = 0.144) and postoperative morbidity rates ( = 0.639) were similar, and there was no postoperative mortality in either group. Postoperative hospital stay was significantly longer in the open group compared to the laparoscopy group (8 (6-11) days vs. 5 (4-7) days, = 0.028). The 1-, 3-, and 5-year disease-free survival rates showed no difference between the two groups (44.6% vs. 62.5%, 16.5% vs. 13.5%, and 8.3% vs. 13.5%, respectively; = 0.154). The 1-, 3-, and 5-year overall survival rates between the two groups were also similar (85.7% vs. 96.8%, 79.6% vs. 86.0%, and 79.6% vs. 79.4%, respectively; = 0.480). : Laparoscopic salvage hepatectomy shows oncologic outcomes comparable to the open approach with faster postoperative recovery rates. Considering that recurrence rates are high after RFA, the laparoscopic approach should be considered as a first-line option in selected patients.

摘要

尽管射频消融 (RFA) 被广泛用作治疗肝细胞癌 (HCC) 的有效局部治疗方法,但关于 RFA 后局部复发行挽救性肝切除术的证据有限。本研究旨在比较 RFA 后复发 HCC 行挽救性肝切除时开放手术与腹腔镜手术的效果。

在单中心的一家三级转诊中心,2004 年 1 月至 2022 年 8 月期间行肝切除术的患者中,选择了 55 例因 RFA 后边缘复发而行挽救性肝切除术的患者。23 例 (41.8%) 患者采用开放手术,32 例 (58.2%) 患者行腹腔镜手术。比较两组的短期和长期结果。

在开放组中更常进行主要肝切除术 (9 例 [39.1%] vs. 4 例 [12.5%], = 0.022)。开放组术中出血量也更大 (450 (325-750) vs. 300 (200-600), = 0.034)。手术时间 ( = 0.144) 和术后并发症发生率 ( = 0.639) 相似,两组均无术后死亡。与腹腔镜组相比,开放组的术后住院时间明显更长 (8 (6-11) 天 vs. 5 (4-7) 天, = 0.028)。两组的 1、3 和 5 年无疾病生存率无差异 (44.6% vs. 62.5%,16.5% vs. 13.5%,8.3% vs. 13.5%; = 0.154)。两组的 1、3 和 5 年总生存率也相似 (85.7% vs. 96.8%,79.6% vs. 86.0%,79.6% vs. 79.4%; = 0.480)。

腹腔镜挽救性肝切除术的肿瘤学结果与开放手术相当,且术后恢复更快。考虑到 RFA 后复发率较高,腹腔镜手术应作为选择患者的一线治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859d/10384708/442a182b2768/medicina-59-01243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859d/10384708/7783547085c8/medicina-59-01243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859d/10384708/442a182b2768/medicina-59-01243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859d/10384708/7783547085c8/medicina-59-01243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859d/10384708/442a182b2768/medicina-59-01243-g002.jpg

相似文献

1
Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation.射频消融后复发性肝细胞癌行挽救性肝切除术中开腹与腹腔镜手术的比较。
Medicina (Kaunas). 2023 Jul 4;59(7):1243. doi: 10.3390/medicina59071243.
2
Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma.一项前瞻性单中心队列研究,分析完全腹腔镜切除术对复发性肝细胞癌的疗效。
Chin J Cancer. 2016 Mar 8;35:25. doi: 10.1186/s40880-016-0088-0.
3
The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.单发 5cm 或以下肝癌射频消融治疗的 10 年生存分析:原发性与复发性 HCC。
Radiology. 2021 Aug;300(2):458-469. doi: 10.1148/radiol.2021200153. Epub 2021 May 18.
4
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.射频消融与再次切除治疗初始根治性切除后复发的≤5cm 肝细胞癌。
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
5
Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.微创外科手术与射频消融治疗直径≤2cm且肝功能代偿的单发性包膜下肝细胞癌的比较
Surg Endosc. 2020 Dec;34(12):5566-5573. doi: 10.1007/s00464-019-07357-x. Epub 2020 Jan 28.
6
Endoscopic versus open radiofrequency ablation for treatment of small hepatocellular carcinoma.内镜与开放式射频消融治疗小肝癌的比较。
World J Surg. 2013 Mar;37(3):597-601. doi: 10.1007/s00268-012-1868-6.
7
Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.射频消融治疗后复发性肝细胞癌挽救性肝切除的疗效
Surgery. 2015 Mar;157(3):463-72. doi: 10.1016/j.surg.2014.10.019. Epub 2014 Dec 9.
8
Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.肝癌切除术后肝内复发再切除与射频消融的生存分析。
World J Surg. 2012 Jan;36(1):151-6. doi: 10.1007/s00268-011-1323-0.
9
A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation.老年恶性肝肿瘤患者行腹腔镜肝切除与射频消融术的围手术期结局比较
Surg Endosc. 2017 Mar;31(3):1269-1274. doi: 10.1007/s00464-016-5105-5. Epub 2016 Jul 21.
10
Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.经导管动脉化疗栓塞联合射频消融与肝切除术治疗初始手术后复发性肝细胞癌的比较:倾向评分匹配研究。
Eur Radiol. 2018 Aug;28(8):3522-3531. doi: 10.1007/s00330-017-5166-4. Epub 2018 Mar 13.

本文引用的文献

1
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.2022 KLCA-NCC 韩国肝细胞癌管理实践指南。
Clin Mol Hepatol. 2022 Oct;28(4):583-705. doi: 10.3350/cmh.2022.0294. Epub 2022 Oct 1.
2
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly.韩国的肝细胞癌发病率正在下降,但在非常老年人群中却在上升。
Clin Mol Hepatol. 2023 Jan;29(1):120-134. doi: 10.3350/cmh.2021.0395. Epub 2022 Aug 12.
3
Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis.
腹腔镜与开腹肝切除术治疗老年肝细胞癌的比较:倾向评分匹配分析。
HPB (Oxford). 2022 Jun;24(6):933-941. doi: 10.1016/j.hpb.2021.10.024. Epub 2021 Nov 6.
4
Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma.手术与射频消融治疗 Child-Pugh 分级 A/单发小肝癌(≤3 cm)。
Clin Mol Hepatol. 2022 Apr;28(2):207-218. doi: 10.3350/cmh.2021.0294. Epub 2021 Nov 24.
5
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐:2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
6
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.腹腔镜与开腹肝切除术治疗伴有 Child-Pugh B 级肝硬化的肝细胞癌:多中心倾向评分匹配研究。
Br J Surg. 2021 Mar 12;108(2):196-204. doi: 10.1093/bjs/znaa041.
7
Laparoscopic liver resection: indications, limitations, and economic aspects.腹腔镜肝切除术:适应证、局限性和经济方面。
Langenbecks Arch Surg. 2020 Sep;405(6):725-735. doi: 10.1007/s00423-020-01918-8. Epub 2020 Jul 1.
8
Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy.射频消融治疗后复发性肝细胞癌的肝切除术
Hepatol Res. 2019 Apr;49(4):432-440. doi: 10.1111/hepr.13293. Epub 2019 Jan 2.
9
Laparoscopic liver resection for hepatocellular carcinoma in early and advanced cirrhosis.腹腔镜肝切除术治疗早期和晚期肝硬化患者的肝细胞癌
HPB (Oxford). 2018 Jun;20(6):521-529. doi: 10.1016/j.hpb.2017.11.011. Epub 2018 Jan 6.
10
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.经皮治疗肝细胞癌:现状与创新。
J Hepatol. 2018 Apr;68(4):783-797. doi: 10.1016/j.jhep.2017.10.004. Epub 2017 Oct 13.